使用人类诱导多能干细胞进行疾病建模的技术挑战。
Technical challenges in using human induced pluripotent stem cells to model disease.
机构信息
The Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
出版信息
Cell Stem Cell. 2009 Dec 4;5(6):584-95. doi: 10.1016/j.stem.2009.11.009.
Abstract
Reprogramming of human somatic cells uses readily accessible tissue, such as skin or blood, to generate embryonic-like induced pluripotent stem cells (iPSCs). This procedure has been applied to somatic cells from patients who are classified into a disease group, thus creating "disease-specific" iPSCs. Here, we examine the challenges and assumptions in creating a disease model from a single cell of the patient. Both the kinetics of disease onset and progression as well as the spatial localization of disease in the patient's body are challenges to disease modeling. New tools in genetic modification, reprogramming, biomaterials, and animal models can be used for addressing these challenges.
摘要
人类体细胞的重编程利用易于获得的组织，如皮肤或血液，来产生类似胚胎的诱导多能干细胞（iPSCs）。该方法已应用于来自患者的体细胞，从而产生“疾病特异性”iPSCs。在这里，我们研究了从患者的单个细胞创建疾病模型所面临的挑战和假设。疾病的发病和进展的动力学以及患者体内疾病的空间定位都是疾病建模的挑战。遗传修饰、重编程、生物材料和动物模型方面的新工具可用于应对这些挑战。
相似文献
1
Technical challenges in using human induced pluripotent stem cells to model disease.使用人类诱导多能干细胞进行疾病建模的技术挑战。
Cell Stem Cell. 2009 Dec 4;5(6):584-95. doi: 10.1016/j.stem.2009.11.009.
2
A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.一种新型的泌尿道分化、组织再生和疾病模型：将人类前列腺和膀胱细胞重编程为诱导多能干细胞。
Eur Urol. 2013 Nov;64(5):753-61. doi: 10.1016/j.eururo.2013.03.054. Epub 2013 Apr 6.
3
Mitochondrial resetting and metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling.诱导多能干细胞中的线粒体重设与代谢重编程及线粒体疾病建模
Biochim Biophys Acta. 2016 Apr;1860(4):686-93. doi: 10.1016/j.bbagen.2016.01.009. Epub 2016 Jan 15.
4
An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.直接体细胞重编程概述：诱导多能干细胞的来龙去脉
Int J Mol Sci. 2016 Jan 21;17(1):141. doi: 10.3390/ijms17010141.
5
Evolution of induced pluripotent stem cell technology.诱导多能干细胞技术的演进。
Curr Opin Hematol. 2010 Jul;17(4):276-80. doi: 10.1097/MOH.0b013e328339f2ee.
6
Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling.诱导多能干细胞和诱导多能癌细胞在癌症疾病建模中的应用。
Adv Exp Med Biol. 2018;1119:169-183. doi: 10.1007/5584_2018_257.
7
An Insight into Reprogramming Barriers to iPSC Generation.重编程 iPSC 生成障碍的洞察。
Stem Cell Rev Rep. 2020 Feb;16(1):56-81. doi: 10.1007/s12015-019-09931-1.
8
Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells.血液T细胞的分化：将人类诱导多能干细胞重编程为神经元细胞。
J Chin Med Assoc. 2015 Jun;78(6):353-9. doi: 10.1016/j.jcma.2015.03.007. Epub 2015 May 26.
9
Tissue-Restricted Stem Cells as Starting Cell Source for Efficient Generation of Pluripotent Stem Cells: An Overview.组织受限干细胞作为高效生成多能干细胞的起始细胞来源：概述。
Adv Exp Med Biol. 2022;1376:151-180. doi: 10.1007/5584_2021_660.
10
Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status.无转基因人类诱导多能干细胞的产生与特性鉴定及向推定临床级状态的转化。
Stem Cell Res Ther. 2013 Jul 26;4(4):87. doi: 10.1186/scrt246.
引用本文的文献
1
Clinical characteristics and induced pluripotent stem cells (iPSCs) disease model of Harel-Yoon syndrome caused by compound heterozygous ATAD3A variants.由复合杂合性ATAD3A变异引起的哈雷尔-尹综合征的临床特征及诱导多能干细胞（iPSCs）疾病模型
Hum Cell. 2025 Apr 17;38(3):90. doi: 10.1007/s13577-025-01214-x.
2
A review: Carrier-based hydrogels containing bioactive molecules and stem cells for ischemic stroke therapy.综述：用于缺血性中风治疗的含生物活性分子和干细胞的载体制备水凝胶
Bioact Mater. 2025 Mar 5;49:39-62. doi: 10.1016/j.bioactmat.2025.01.014. eCollection 2025 Jul.
3
Using cortical organoids to understand the pathogenesis of malformations of cortical development.利用皮质类器官了解皮质发育畸形的发病机制。
Front Neurosci. 2025 Jan 15;18:1522652. doi: 10.3389/fnins.2024.1522652. eCollection 2024.
4
Stem Cell Therapy for Diseases of Livestock Animals: An In-Depth Review.家畜疾病的干细胞疗法：深入综述
Vet Sci. 2025 Jan 17;12(1):67. doi: 10.3390/vetsci12010067.
5
Generation of an Isogenic Hereditary Hemorrhagic Telangiectasia Model via Prime Editing in Human Induced Pluripotent Stem Cells.通过对人类诱导多能干细胞进行碱基编辑生成同基因遗传性出血性毛细血管扩张症模型。
Int J Stem Cells. 2024 Nov 30;17(4):397-406. doi: 10.15283/ijsc24084. Epub 2024 Sep 6.
6
An efficient low cost means of biophysical gene transfection in primary cells.一种高效、低成本的原代细胞生物物理基因转染方法。
Sci Rep. 2024 Jun 8;14(1):13179. doi: 10.1038/s41598-024-62996-y.
7
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.探索诱导多能干细胞在癌症研究和治疗中的广阔前景。
Mol Cancer. 2023 Nov 28;22(1):189. doi: 10.1186/s12943-023-01873-0.
8
Purinergic Signaling and its Role in the Stem Cell Differentiation.嘌呤能信号及其在干细胞分化中的作用。
Mini Rev Med Chem. 2024;24(8):863-883. doi: 10.2174/0113895575261206231003151416.
9
Epigenetic dynamics during capacitation of naïve human pluripotent stem cells.原始人类多能干细胞获能过程中的表观遗传动力学
Sci Adv. 2023 Sep 29;9(39):eadg1936. doi: 10.1126/sciadv.adg1936.
10
Arouse potential stemness: Intrinsic and acquired stem cell therapeutic strategies for advanced liver diseases.激发潜在干性：晚期肝病的内在和获得性干细胞治疗策略。
Cell Insight. 2023 Aug 11;2(5):100115. doi: 10.1016/j.cellin.2023.100115. eCollection 2023 Oct.
本文引用的文献
1
Direct cell reprogramming is a stochastic process amenable to acceleration.直接细胞重编程是一个适合加速的随机过程。
Nature. 2009 Dec 3;462(7273):595-601. doi: 10.1038/nature08592. Epub 2009 Nov 8.
2
Generation of functional human hepatic endoderm from human induced pluripotent stem cells.从人诱导多能干细胞生成功能性人肝内胚层。
Hepatology. 2010 Jan;51(1):329-35. doi: 10.1002/hep.23335.
3
Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome.利用基于 RNA 病毒仙台病毒的载体高效诱导无转基因的人多能干细胞，该病毒不会整合到宿主基因组中。
Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(8):348-62. doi: 10.2183/pjab.85.348.
4
New strategies to generate induced pluripotent stem cells.生成诱导多能干细胞的新策略。
Curr Opin Biotechnol. 2009 Oct;20(5):516-21. doi: 10.1016/j.copbio.2009.09.005.
5
Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells.活细胞成像可区分真正的人类诱导多能干细胞和部分重编程细胞。
Nat Biotechnol. 2009 Nov;27(11):1033-7. doi: 10.1038/nbt.1580. Epub 2009 Oct 11.
6
A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog.TGF-β 信号小分子抑制剂通过诱导 Nanog 在重编程中替代 Sox2。
Cell Stem Cell. 2009 Nov 6;5(5):491-503. doi: 10.1016/j.stem.2009.09.012. Epub 2009 Oct 8.
7
Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells.从成人脂肪干细胞中无饲养层诱导多能干细胞的衍生
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15720-5. doi: 10.1073/pnas.0908450106. Epub 2009 Sep 8.
8
Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.健康供者和获得性血液疾病患者血细胞诱导的多能干细胞。
Blood. 2009 Dec 24;114(27):5473-80. doi: 10.1182/blood-2009-04-217406. Epub 2009 Oct 1.
9
Generation of induced pluripotent stem cells from human cord blood.从人脐带血中诱导生成多能干细胞。
Cell Stem Cell. 2009 Oct 2;5(4):434-41. doi: 10.1016/j.stem.2009.08.021.
10
Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2.利用OCT4和SOX2从人脐带血中生成诱导多能干细胞。
Cell Stem Cell. 2009 Oct 2;5(4):353-7. doi: 10.1016/j.stem.2009.09.008.
Zotero 插件